P70 Exposure to DORIS ≥50% of time and to LLDAS ≥60% of observation time exhibit the best combination of feasibility and protection against adverse outcomes in moderate-to-severe SLE

• Alessandra Bortoluzzi,
• Marcello Govoni,
• Prodromos Sidiropoulos,
• George Bertsias,
• Konstantinos Parperis,
• Argyro Repa,
• Dimitrios Boumpas,
• Ettore Silvagni,
• Myrto Nikoloudaki,
• Nestor Avgoustidis,
• Panagiotis Garantziotis,
• Sofia Pitsigavdaki,
• Antonio Marangoni,
• Irini Flouri

Affiliations

Alessandra Bortoluzzi

Azienda Ospedaliera-Universitaria di Ferrara (Cona FE), Cona FE, Italy

Marcello Govoni

4Rheumatology Clinic, University of Ferrara, Ferrara, Italy

Prodromos Sidiropoulos

Department of Rheumatology, Clinical Immunology and Allergy, School of Medicine, University of Crete, University Hospital of Heraklion, Heraklion, Greece

George Bertsias

1Rheumatology and Clinical Immunology, University of Crete Medical School, Heraklion, Greece

Konstantinos Parperis

5Division of Rheumatology, Department of Medicine, University of Cyprus Medical School, Nicosia, Cyprus

Argyro Repa

Rheumatology, Clinical Immunology and Allergy, University of Crete School of Medicine, Heraklion, Crete, Greece

Dimitrios Boumpas

7Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine, Attikon University Hospital, Joint Rheumatology Program, National and Kapodistrian University of Athens Medical School, Athens, Greece

Ettore Silvagni

Section of Rheumatology, Department of Medical Sciences, University of Ferrara, Ferrara, Italy

Myrto Nikoloudaki

1 Rheumatology and Clinical Immunology, University of Crete School of Medicine, Heraklion, Greece

Nestor Avgoustidis

1 Rheumatology and Clinical Immunology, University of Crete School of Medicine, Heraklion, Greece

Panagiotis Garantziotis

1 Laboratory of Autoimmunity and Inflammation, Biomedical Research Foundation of the Academy of Athens, Athens, Greece

Sofia Pitsigavdaki

1 Rheumatology and Clinical Immunology, University of Crete School of Medicine, Heraklion, Greece

Antonio Marangoni

4 Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria S.Anna, Ferrara, Italy

Irini Flouri

1 Rheumatology and Clinical Immunology, University of Crete School of Medicine, Heraklion, Greece